CMI (NYSE: CMI) Form 144 lists 3,144; 1,623; 233 award shares to be sold

Rhea-AI Filing Summary

CMI filed a Form 144 proposing the sale of Common Stock consisting of 3,144, 1,623 and 233 shares that were acquired as performance awards on 03/01/2026, 02/19/2026, and 02/19/2025, respectively.

The notice names Goldman Sachs & Co. LLC and references the NYSE; the filing includes a transaction-related line showing 5,000 in one field and the date 05/12/2026.

Insights

Securities Compliance Attorney

Form 144 notifies the market of proposed brokered sales of shares earned as performance awards.

Form 144 provides notice that an affiliate or holder intends to sell specified common shares; the filing lists discrete lots of 3,144, 1,623 and 233 shares tied to performance awards on explicit dates. Exact cash‑flow treatment and whether sales occur via block trades, brokerage transactions, or other methods are not detailed in the excerpt.

Compliance risk centers on timing and Rule 144 eligibility; the filing names a broker and an NYSE listing, and subsequent filings or execution reports will show whether these proposed sales were completed.

Equity Capital Markets Analyst

The notice lists small, discrete award lots rather than a single large block, suggesting routine insider liquidity.

The excerpt shows three award lots (3,144; 1,623; 233 shares) acquired as compensation on specified dates. The presence of a broker name indicates intended market execution, but the excerpt does not specify pricing, proceeds, or execution method.

Market impact is likely minimal given the lot sizes shown; follow-up filings or transaction reports will confirm whether sales were executed and at what scale.

Key Figures

Proposed sale lot 1: 3,144 shares Proposed sale lot 2: 1,623 shares Proposed sale lot 3: 233 shares +2 more

5 metrics

Proposed sale lot 1 3,144 shares acquired as performance awards on 03/01/2026

Proposed sale lot 2 1,623 shares acquired as performance awards on 02/19/2026

Proposed sale lot 3 233 shares acquired as performance awards on 02/19/2025

Broker field value 5,000 numeric field appearing alongside Goldman Sachs & Co. LLC and NYSE in the excerpt

Filing reference date 05/12/2026 date shown in the securities header line

Key Terms

Form 144, Performance Awards, Issuer

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Performance Awards financial

"Acquired as compensation -- Performance Awards"

Issuer regulatory

"Acquired as compensation -- Performance Awards | Issuer"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	5000	3522800	137989067	05/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2026	Acquired as compensation -- Performance Awards	Issuer			3144	03/01/2026	Compensation
Common	02/19/2026	Acquired as compensation -- Performance Awards	Issuer			1623	02/19/2026	Compensation
Common	02/19/2025	Acquired as compensation -- Performance Awards	Issuer			233	02/19/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CMI's Form 144 disclose about shares to be sold?

The Form 144 discloses proposed sales of 3,144, 1,623 and 233 common shares, each acquired as performance awards on 03/01/2026, 02/19/2026, and 02/19/2025.

Who is listed as the broker or placement agent on the CMI Form 144?

The filing names Goldman Sachs & Co. LLC in the securities section, indicating a broker role is noted in the excerpt and tied to the proposed sales.

Does the Form 144 excerpt state how the shares will be sold?

The excerpt lists the broker and NYSE but does not specify the method (block trade, brokerage transaction, or privately negotiated sale) or sale pricing in the provided text.

Are the shares listed on Form 144 recently acquired or older awards?

The shares were acquired as performance awards on three dates: 03/01/2026, 02/19/2026, and 02/19/2025, as shown in the excerpt.

Does the Form 144 show total proceeds or pricing for the proposed sales?

The provided excerpt does not disclose sale prices or aggregate proceeds; it lists share lots and a broker name but no pricing or aggregate consideration.